Related Experiment Video

Updated: Jun 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Benefit of statins in daily practice? A six-year retrospective observational study

P Deambrosis1, G Terrazzani, T Walley

  • 1Pharmaceutical Service, Local Health Authority, Treviso, Italy.

Pharmacological Research
|July 4, 2009
PubMed

Insights

This study on hypercholesterolemic patients found that while statin adherence improves cholesterol levels, it surprisingly increased hospitalization risk. Older age and male gender were linked to higher hospitalization risk.

Area of Science:

  • Cardiology
  • Pharmacoeconomics
  • Public Health

Background:

  • Hypercholesterolemia poses a significant risk for coronary events.
  • Statin therapy is a cornerstone in managing high cholesterol.
  • Patient adherence to statin medication is crucial for treatment efficacy.

Purpose of the Study:

  • To investigate the association between statin adherence and achieving target cholesterol levels.
  • To examine the relationship between statin adherence and time to first coronary event hospitalization.
  • To identify factors influencing cholesterol management and hospitalization in hypercholesterolemic patients.

Main Methods:

  • Observational retrospective study design.
  • Analysis of 3516 hypercholesterolemic patients treated with statins (1998-2003).
  • Stratification of patients based on adherence levels (good, poor, nonadherent).

Main Results:

  • Significant reductions in total cholesterol (CL) observed across all adherence groups (p<0.001).
  • Higher statin adherence, older age, and male gender were associated with achieving target CL (<200mg/dl).
  • Contrary to expectations, improved statin adherence correlated with an increased risk of hospitalization.

Conclusions:

  • Statin adherence is effective in lowering cholesterol levels in hypercholesterolemic patients.
  • Factors like age and gender influence cholesterol management success.
  • The unexpected finding of increased hospitalization risk with better adherence warrants further investigation.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...